Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Gross Profit 2017–2025
Aclaris Therapeutics, Inc. annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Aclaris Therapeutics, Inc. gross profit for the quarter ending March 31, 2026 was 1.6 M, a 68.70% increase year-over-year.
- Aclaris Therapeutics, Inc. gross profit for the twelve months ending March 31, 2026 was 6.6 M, a 58.55% decrease year-over-year.
- Aclaris Therapeutics, Inc. annual gross profit for 2025 was 5.7 M, a 63.99% decrease from 2024.
- Aclaris Therapeutics, Inc. annual gross profit for 2024 was 15.9 M, a 42.76% decrease from 2023.
- Aclaris Therapeutics, Inc. annual gross profit for 2023 was 27.8 M, a 8.15% increase from 2022.
- Aclaris Therapeutics, Inc. annual gross profit for 2022 was 25.7 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aclaris Therapeutics, Inc. Gross Profit — FAQ
Aclaris Therapeutics, Inc. (ACRS) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Aclaris Therapeutics, Inc.'s gross profit?
Aclaris Therapeutics, Inc. (ACRS) reported gross profit of $6M for fiscal 2025.
Where can I see ACRS's gross profit history?
The chart and table above show Aclaris Therapeutics, Inc.'s gross profit by year and by quarter, including the growth rate.